Theranostics is a new field of medicine which combines specific targeted therapy based on specific targeted diagnostic tests.

Theranostics uses specific biological pathways in the human body, to acquire diagnostic images and also to deliver a therapeutic dose of radiation to the patient.

Wesley Medical Imaging currently offers three Theranostics treatments:


1. Lutetium PSMA Therapy

Lutetium-177 PSMA Therapy, or Lutetium-177 Prostate-Specific Membrane Antigen Therapy is a treatment for men with advanced prostate cancer. It is to be used predominantly when the disease has metastasised and other treatments have been poorly tolerated or failed.


2. Yttrium 90 SIRT Therapy

Yttrium-90 SIRT Therapy, or Selective Internal Radiation Therapy, is a treatment for cancers and tumours that are located within the liver. The aim of this treatment is to reduce tumour size in inoperable tumours or decrease the number of lesions in the liver. Occasionally this may lead to consideration for surgical removal of the tumours. This may also stabilise disease and prolong life.


3. Lutetium Octreotate Therapy

Lutetium-177 Octreotate Therapy is used as a treatment for people with tumours that emerge from the endocrine or nervous system; these are called neuroendocrine tumours (NETs) or carcinoids. This therapy aims to reduce the size of the tumour/s and stop them from multiplying, as well as to ease the symptoms that people may get with these tumours. In a number of patients this can lead to long term remission of the disease.

  • View our Lutetium Octreotate Therapy procedure information.